Wahi a nā kānaka ʻepekema, ʻo nā lāʻau lapaʻau e hoʻohana ʻia no ke ʻano maʻi type 2 hiki ke ʻoki i ka hopena o ka ulu ʻana o ka maʻi Parkinson.
Ua ʻike nā kānaka ʻepekema o Noremania i nā mea maʻi e hoʻohana iā Glutazone (GTZ), ʻo ka hopena o ke kūkulu ʻana i kahi maʻi degenerative kahi hapa haʻahaʻa ma hope inā mākou e noʻonoʻo i ka pakeneka. Ua hoʻohana ʻia ʻo GTZ, i ʻike ʻia ma Rū ma lalo o ka inoa ʻo Thiazolidinedione, no ke ʻano maʻi maʻi lua. Me ia, hiki iā ʻoe ke hoʻonui i ka naʻau o ke kino no ka insulin, nona ke kuleana no ka hoʻoponopono ʻana i ke kō.
No ka ʻike ʻana i ka pili ma waena o ka hoʻohana ʻana o ka maʻi GTZ a me ka maʻi Parkinson, ua hana nā kānaka ʻepekema i kahi loiloi o nā mea maʻi i hāʻawi ʻia i kēia lāʻau lapaʻau e like me ka kuhikuhi ʻana. Ua huki hou nā kānaka noiʻi i ka pehea o ka metformin, kahi o ka lāʻau lapaʻau i kauoha ʻia no ka maʻi maʻi lua, e pili ana i ka hoʻomohala ʻana o ka maʻi Parkinson. No nā makahiki he ʻumi mai Ianuali 2005 a hiki i Dekemaba 2014, ua ʻike nā mea noiʻi ma mua o 94.3 tausani mau kānaka e hoʻohana ana i ka metformin, a kokoke he 8.4 mano o GTZ.
Wahi a nā hopena o nā hana ʻepekema, hōʻike ʻia nā mea maʻi i hoʻohana i ka lāʻau hou, aneane he hapakolu i haʻahaʻa ka hoʻomau ʻana i ka maʻi o Parkinson. ʻAʻole lawa ka ʻikepili ʻepekema e wehewehe pono i ka mekanica i lalo i ko lākou mau ʻike, akā manaʻo lākou ua alakaʻi ʻo GTZ i ka hana mitochondrial maikaʻi aʻe.
"Pēlā paha e hoʻonui ai ke ʻano o ka syntito o ka mitochondrial DNA a me ka nui o ka lehulehu o ka inoa like me ka huina GTZ," wahi a nā mea kākau o ke noiʻi.
Wahi a nā kānaka ʻepekema, ʻo ke aʻo ʻana e lilo i kumu no nā kuhikuhi e pili ana i ka pale ʻana a me ka mālama ʻana i nā maʻi o Parkinson.
"ʻO ka ʻike hou i loaʻa iā mākou e hoʻokokoke ake ana i ka hoʻoholo ʻana o nā pilikia i pili i ka maʻi o Parkinson," i ʻōlelo ai ka mea kākau.
